Research Interests

Our research focuses on developing cancer immunotherapy. We are inventing and evaluating novel therapies from preclinical research to clinical trials. We work in close contact with small biotech companies such as the Swedish based Lokon Pharma for product development.

The aim of cancer immunotherapy is to restart the immune cells to target and kill cancer cells by virtually the same mechanisms as used to kill virally infected cells. There are many approaches being tested in clinical trials around the world with promising effects. We have focused on CAR T cells and adenovirus-mediated immunostimulatory gene therapy.

CAR T Cells

T cells expressing chimeric antigen receptors that allow T cells to specifically recognize and kill CD19 positive B cells are being developed in our group. We are performing a clinical Phase I/IIa trial using gene engineered T cells for patients with B cell lymphoma and leukemia together with Uppsala University Hospital (Prof Gunilla Enblad and Asc Prof Hans Hagberg) and in collaboration with Baylor College of Medicine, Houston, and Vecura, Karolinska University Hospital.

Immunostimulatory Gene Therapy

Direct injection of gene therapy vehicles expressing immunostimulatory genes into the tumor microenvironment is being developed as a novel therapy for patients with solid tumors. In a clinical trial on malignant melanoma we are evaluating the effect of a replication-deficient adenovirus transferring the CD40L gene into the tumor. This study is done in collaboration with Prof Thomas Tötterman at Uppsala University and Asc Prof Gustav Ullenhag at Uppsala University Hospital.

For pancreatic cancer, we are developing a novel oncolytic adenovirus with immunostimulatory genes called LOAd together with Lokon Pharma and a trial is currently being planned.

Group members

Angelica Loskog, PhD, Professor of Immunotherapy (adj)
Joachim Burman, Post doc
Hannah Karlsson, PhD student
Emma Svensson, PhD student
Stina Söderlund, PhD student
Ioanna Milenova, research assistant
Wictor Gustafson, research assistant

Contact

angelica.loskog@igp.uu.se

 
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.